Ashutosh S. Jogalekar, Ph.D.
Affiliations: | 2014- | Chemistry | Warp Drive Bio |
Area:
Medicinal, Bioorganic, Synthetic Organic, ComputationalGoogle:
"Ashutosh Jogalekar"Mean distance: 9.82 | S | N | B | C | P |
Parents
Sign in to add mentor| Dennis C. Liotta | grad student | 2009 | Emory | |
| (Part I: Conformational analysis of bioactive molecules in solution. Part II: Structure-based design of selective inhibitors of cyclin-dependent kinase 7.) | ||||
| Richard V. Wolfenden | post-doc | 2008-2009 | UNC Chapel Hill | |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Koltun ES, Aay N, Buckl A, et al. (2018) Abstract 4878: RMC-4550, an allosteric inhibitor of SHP2: Synthesis, structure, and anti-tumor activity Cancer Research. 78: 4878-4878 |
| Wildes D, Aay N, Buckl A, et al. (2018) Abstract 4877: Allosteric inhibition of SHP2 variants containing cancer-associated activating mutations Cancer Research. 78: 4877-4877 |
| Jogalekar AS, Damodaran K, Kriel FH, et al. (2011) Dictyostatin flexibility bridges conformations in solution and in the β-tubulin taxane binding site. Journal of the American Chemical Society. 133: 2427-36 |
| Heathcote DA, Patel H, Kroll SH, et al. (2010) A novel pyrazolo[1,5-a]pyrimidine is a potent inhibitor of cyclin-dependent protein kinases 1, 2, and 9, which demonstrates antitumor effects in human tumor xenografts following oral administration. Journal of Medicinal Chemistry. 53: 8508-22 |
| Jogalekar AS. (2010) Conformations of stevastelin C3 analogs: Computational deconvolution of NMR data reveals conformational heterogeneity and novel motifs Biopolymers. 93: 968-976 |
| Jogalekar AS, Kriel FH, Shi Q, et al. (2010) The discodermolide hairpin structure flows from conformationally stable modular motifs Journal of Medicinal Chemistry. 53: 155-165 |
| Ali S, Heathcote DA, Kroll SH, et al. (2009) The development of a selective cyclin-dependent kinase inhibitor that shows antitumor activity. Cancer Research. 69: 6208-15 |